Remember 1995? It was a long time ago, so you can be forgiven for not recalling much of it. To re-orient you: it was President Clinton’s first term; the Oklahoma City bombing happened in April; a jury found O.J. Simpson not guilty of two murders; Apple was still trying to sell the Newton. And Total,… Continue Reading
Category Archives: FCPA
Subscribe to FCPA RSS FeedRalph Lauren Escapes FCPA Problems with Minimized Damage
Posted in FCPAOften, enforcement officials at the SEC and the Justice Department express their wish that securities law violators own up to their (mis)conduct as soon it comes to light. That is, come to the government and explain what has happened. Almost as often, though, those officials have a difficult time describing the tangible benefits of doing… Continue Reading
SEC Charges Allianz with FCPA Violations
Posted in FCPA, Non-scienter-based Violations, WhistleblowersOn December 17th, the SEC brought a settled administrative FCPA action against Allianz SE, a German insurance company with a subsidiary in Indonesia. The order does not allege violations of the FCPA’s antibribery provisions, but does claim violations of its books-and-records and internal controls provisions. As the summary in the SEC’s order says, the proceedings… Continue Reading
FCPA Declination Opinions? SEC and DOJ Sort of Have Them
Posted in FCPAThe Justice Department and the SEC released long-awaited joint guidance on enforcement and compliance with the Foreign Corrupt Practices Act yesterday. Many have pointed out that the guidance does not cover much new ground but does compile a good deal of information that was previously scattered among different sources. One of the things the guidance… Continue Reading
Stories Worth Reading This Morning
Posted in Broker-Dealers, FCPA, FINRAAmong the stories you should consider reading today: FINRA’s Susan Axelrod announced at a PLI panel on Wednesday that FINRA is reviewing conflicts of interest at 14 broker-dealers. The review seems to be geared toward being sure that registered representatives keep their focus on suitability of the products sold to their customers. This article suggests… Continue Reading
Back from the Securities Enforcement Forum 2012
Posted in FCPA, SEC LitigationYesterday I attended the Securities Enforcement Forum 2012 at the Mayflower Hotel in D.C. Bruce Carton organized an excellent day of panels devoted to a number of securities enforcement topics. Here is the full agenda from the day. Several things jumped out at me as noteworthy. More Use of Section 21(a) Reports The Hon. Stanley… Continue Reading
Even Domestic Bribery Falls within the SEC’s Jurisdiction
Posted in Accounting Fraud, FCPAMuch ink has been spilled in recent years discussing the SEC’s and Justice Department’s focus on the Foreign Corrupt Practices Act, a law that prohibits paying bribes to foreign government officials. While the federal criminal code has provisions prohibiting bribery of domestic public officials, see 18 U.S.C. § 201, domestic bribery has rarely been a… Continue Reading
SEC and DOJ Issue First FCPA Declination Opinions
Posted in FCPASome in the FCPA commentariat have long said that the Justice Department and SEC should publicly issue declination opinions when the agencies decide not to pursue a matter. We already see the factual scenarios that lead those agencies to file charges, in the form of the complaints and indictments themselves. Many have argued that declination… Continue Reading
Siemens Executives Face Parallel FCPA Proceedings
Posted in FCPA, Parallel Proceedings, SEC LitigationSo the SEC and the Justice Department brought a big FCPA case involving Siemens AG on Tuesday. The agencies charged a total of nine former senior executives and agents of the company with a decade-long scheme to bribe Argentinian government officials to secure and implement a $1 billion contract to produce national identity cards. The… Continue Reading
Pfizer’s $60 Million FCPA Pricetag is Likely Only the Beginning
Posted in FCPAThe Wall Street Journal tells us today that Pfizer will soon settle Foreign Corrupt Practices Act charges with the SEC and the Justice Department for a total of $60 million. While that figure doesn’t launch Pfizer into the top ten list of all-time FCPA resolutions, it is quite high, and bumps up against Johnson &… Continue Reading